Translating multimodal foundation models into oncology: Toward a future where AI directs diagnosis and therapy

Translating multimodal foundation models into oncology: Toward a future where AI directs diagnosis and therapyRecent developments in multimodal artificial intelligence (AI) have begun to transform how clinicians approach cancer prognosis and treatment selection.In a recent study, Xiang et al 1 present MUSK (Multimodal Unified Self-supervised learning for Oncology), a foundation model that integrates more than 50 million whole-slide pathology images and over 1 billion oncology-related clinical text tokens.MUSK uses a unified transformer architecture to simultaneously capture morphological and semantic features, enabling the integrated image-text interpretation essential for oncology (Fig. 1A).The model was pretrained in two stages: the first stage employed masked modeling using unpaired data from each modality, while the second stage used approximately one million paired image-text samples with contrastive learning to align histologic and linguistic representations.This approach enabled robust cross-modal understanding, supporting downstream diagnostic and prognostic applications.In comparative evaluations across several cancer types, including non-small cell lung cancer, colorectal carcinoma, gastric adenocarcinoma, and melanoma, MUSK outperformed traditional staging systems and biomarker-based models.In non-small cell lung cancer, the model demonstrated refined stratification of survival risk within the same pathological stage, capturing histologic subtleties and semantic modifiers within pathology reports that may be overlooked by standard criteria.For immunotherapy response prediction, MUSK achieved an AUC of 0.77 versus 0.61 for PD-L1-based classifiers.In patients with melanoma, recurrence risk prediction reached an accuracy of 83%, with the model prioritizing regions of mitotic activity, tumor regression, and lymphovascular infiltration.Interpretability was central to the framework, with visualization tools highlighting key histologic regions and textual descriptors.These interpretive tools may aid pathologists and

Authors

Institutions

Publication Details

Journal
Genes & Diseases
Published
2025-11-28
DOI
https://doi.org/10.1016/j.gendis.2025.101958
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Translating multimodal foundation models into oncology: Toward a future where AI directs diagnosis and therapy

Kyung Chan Park, Wonbeak Yoo
Genes & Diseases
Artificial Intelligence in Healthcare and Education
article

Translating multimodal foundation models into oncology: Toward a future where AI directs diagnosis and therapy

Kyung Chan Park, Wonbeak Yoo
article en

Abstract

Translating multimodal foundation models into oncology: Toward a future where AI directs diagnosis and therapyRecent developments in multimodal artificial intelligence (AI) have begun to transform how clinicians approach cancer prognosis and treatment selection.In a recent study, Xiang et al 1 present MUSK (Multimodal Unified Self-supervised learning for Oncology), a foundation model that integrates more than 50 million whole-slide pathology images and over 1 billion oncology-related clinical text tokens.MUSK uses a unified transformer architecture to simultaneously capture morphological and semantic features, enabling the integrated image-text interpretation essential for oncology (Fig. 1A).The model was pretrained in two stages: the first stage employed masked modeling using unpaired data from each modality, while the second stage used approximately one million paired image-text samples with contrastive learning to align histologic and linguistic representations.This approach enabled robust cross-modal understanding, supporting downstream diagnostic and prognostic applications.In comparative evaluations across several cancer types, including non-small cell lung cancer, colorectal carcinoma, gastric adenocarcinoma, and melanoma, MUSK outperformed traditional staging systems and biomarker-based models.In non-small cell lung cancer, the model demonstrated refined stratification of survival risk within the same pathological stage, capturing histologic subtleties and semantic modifiers within pathology reports that may be overlooked by standard criteria.For immunotherapy response prediction, MUSK achieved an AUC of 0.77 versus 0.61 for PD-L1-based classifiers.In patients with melanoma, recurrence risk prediction reached an accuracy of 83%, with the model prioritizing regions of mitotic activity, tumor regression, and lymphovascular infiltration.Interpretability was central to the framework, with visualization tools highlighting key histologic regions and textual descriptors.These interpretive tools may aid pathologists and

Genes & DiseasesVol. 13(4)
Korea Research Institute of Bioscience and Biotechnology (KR), Korea University of Science and Technology (KR)
Openalex Percentile: Top 69%
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.